Circulation-Cardiovascular Quality and Outcomes

Article	Citations
Race, Racism, and Cardiovascular Health: Applying a Social Determinants of Health Framework to Racial/Ethnic Disparities in Cardiovascular Disease	146
Recommendations for Reporting Machine Learning Analyses in Clinical Research	127
Importance of Housing and Cardiovascular Health and Well-Being: A Scientific Statement From the American Heart Association	81
2021 ACC/AHA Key Data Elements and Definitions for Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to	72
The Groundwater of Racial and Ethnic Disparities Research	71
Rapid Diet Assessment Screening Tools for Cardiovascular Disease Risk Reduction Across Healthcare Settings: A Scientific Statement From the American Heart Association	59
Systemic Inflammatory Response Syndrome Is Associated With Increased Mortality Across the Spectrum of Shock Severity in Cardiac Intensive Care Patients	53
Changes in the United States Adult Heart Allocation Policy	48
Understanding How Cardiac Arrest Complicates the Analysis of Clinical Trials of Cardiogenic Shock	48
Survival in Patients With Suspected Myocardial Infarction With Nonobstructive Coronary Arteries: A Comprehensive Systematic Review and Meta-Analysis From the MINOCA Global Collaboration	47
Cardiovascular and Cerebrovascular Disease Mortality in Asian American Subgroups	46
Obesity Prevalence and Risks Among Chinese Adults: Findings From the China PEACE Million Persons Project, 2014–2018	46
Characteristics and Outcomes of In-Hospital Cardiac Arrest Events During the COVID-19 Pandemic	43
American Heart Association COVID-19 CVD Registry Powered by Get With The Guidelines	42
Utilization and Availability of Advanced Imaging in Patients With Acute Ischemic Stroke	41
2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure	41
Off-Label Under- and Overdosing of Direct Oral Anticoagulants in Patients With Atrial Fibrillation: A Meta-Analysis	40
Harnessing Mobile Health Technology for Secondary Cardiovascular Disease Prevention in Older Adults: A Scientific Statement From the American Heart Association	40
Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation: A Health Economic Analysis	39
Psychological Outcomes and Interventions for Individuals With Congenital Heart Disease: A Scientific Statement From the American Heart Association	39
Contemporary Trends in Hospital Admissions and Outcomes in Patients With Critical Limb Ischemia	36
Comparative Efficacy of 5 Exercise Types on Cardiometabolic Health in Overweight and Obese Adults: A Systematic Review and Network Meta-Analysis of 81 Randomized Controlled Trials	36
Digital Health Intervention in Acute Myocardial Infarction	36
Supervised Exercise Therapy for Symptomatic Peripheral Artery Disease Among Medicare Beneficiaries Between 2017 and 2018: Participation Rates and Outcomes	35
External Validations of Cardiovascular Clinical Prediction Models: A Large-Scale Review of the Literature	35

Use of Mobile Health Applications in Low-Income Populations	33
Cardio-Renal-Metabolic Care Models	33
Cardiovascular Health Score and Lifetime Risk of Cardiovascular Disease	33
Working Agenda for Black Mothers	33
Million Hearts Cardiac Rehabilitation Think Tank: Accelerating New Care Models	32
Compounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: Systematic Review and Meta-Analysis	31
Type 2 Diabetes Mellitus and Impact of Heart Failure on Prognosis Compared to Other Cardiovascular Diseases	30
Patterns of Prescribing Sodium-Glucose Cotransporter-2 Inhibitors for Medicare Beneficiaries in the United States	29
Preventing and Managing Falls in Adults With Cardiovascular Disease: A Scientific Statement From the American Heart Association	29
Impact of COVID-19 Pandemic on Critical Care Transfers for ST-Segment–Elevation Myocardial Infarction, Stroke, and Aortic Emergencies	28
Performance Metrics for the Comparative Analysis of Clinical Risk Prediction Models Employing Machine Learning	27
Socioeconomic and Geographic Characteristics of Hospitals Establishing Transcatheter Aortic Valve Replacement Programs, 2012–2018	27
Bleeding Risk of Direct Oral Anticoagulants in Patients With Heart Failure And Atrial Fibrillation	26
ABCs of Stroke Prevention	25
Generalizability of Cardiovascular Disease Clinical Prediction Models: 158 Independent External Validations of 104 Unique Models	25
Incidence and Factors Associated With Major Amputation in Patients With Peripheral Artery Disease	24
Multiple Vulnerabilities to Health Disparities and Incident Heart Failure Hospitalization in the REGARDS Study	22
Use of ACE (Angiotensin-Converting Enzyme) Inhibitors and Risk of Lung Cancer	21
Comparative Effectiveness and Safety of Oral Anticoagulants Across Kidney Function in Patients With Atrial Fibrillation	21
2021 Interim Guidance to Health Care Providers for Basic and Advanced Cardiac Life Support in Adults, Children, and Neonates With Suspected or Confirmed COVID-19	21
Association of Hypertension and Arterial Blood Pressure on Limb and Cardiovascular Outcomes in Symptomatic Peripheral Artery Disease	21
Microrandomized Trial Design for Evaluating Just-in-Time Adaptive Interventions Through Mobile Health Technologies for Cardiovascular Disease	21
Rural-Urban Differences in Mortality From Ischemic Heart Disease, Heart Failure, and Stroke in the United States	20
Ten-Year Trends in Patient Characteristics, Treatments, and Outcomes in Myocardial Infarction From National Cardiovascular Data Registry Chest Pain–MI Registry	20
Socioeconomic Burden of Rising Methamphetamine-Associated Heart Failure Hospitalizations in California From 2008 to 2018	20
Patient-Perceived Versus Actual Risk of Cardiovascular Disease and Associated Willingness to Consider and Use Prevention Therapy	20
Comparability of Event Adjudication Versus Administrative Billing Claims for Outcome Ascertainment in the DAPT Study	20
Variation in Out-of-Hospital Cardiac Arrest Survival Across Emergency Medical Service Agencies	20
Sudden Cardiac Death in the Young	20
Relationship of Preeclampsia With Maternal Place of Birth and Duration of Residence Among Non-Hispanic Black Women in the United States	19
Transcatheter Aortic Valve Replacement in Low-Population Density Areas	19
Determinants of Hospital Variation in Cardiac Rehabilitation Enrollment During Coronary Artery Disease Episodes of Care	19
Streamlining and Reimagining Prior Authorization Under Value-Based Contracts: A Call to Action From the Value in Healthcare Initiative’s Prior Authorization Learning Collaborative	19
Risk Factors of Coronary Artery Abnormalities and Resistance to Intravenous Immunoglobulin Plus Corticosteroid Therapy in Severe Kawasaki Disease	19
Characteristics and Quality of National Cardiac Registries: A Systematic Review	18
Relationship Between Preexisting Cardiovascular Disease and Death and Cardiovascular Outcomes in Critically Ill Patients With COVID-19	18
County-Level Social Vulnerability is Associated With In-Hospital Death and Major Adverse Cardiovascular Events in Patients Hospitalized With COVID-19: An Analysis of the American Heart Association COV	18
Cardiometabolic Center of Excellence: A Novel Care Delivery Model for Secondary Prevention of Cardiovascular Disease in Type 2 Diabetes	17
Efficacy and Safety of Chinese Herbal Medicine Compared With Losartan for Mild Essential Hypertension: A Randomized, Multicenter, Double-Blind, Noninferiority Trial	17
Higher Emergency Physician Chest Pain Hospitalization Rates Do Not Lead to Improved Patient Outcomes	17
Examining the Nocebo Effect of Statins Through Statin Adverse Events Reported in the Food and Drug Administration Adverse Event Reporting System	17
Role of Frailty in Identifying Benefit From Transcatheter Versus Surgical Aortic Valve Replacement	17
Impact of Produce Prescriptions on Diet, Food Security, and Cardiometabolic Health Outcomes: A Multisite Evaluation of 9 Produce Prescription Programs in the United States	16
The Heart Failure Readmission Intervention by Variable Early Follow-up (THRIVE) Study	16
Estimating the Effect of Reduced Attendance at Emergency Departments for Suspected Cardiac Conditions on Cardiac Mortality During the COVID-19 Pandemic	16
Food Insecurity and Cardiovascular Mortality for Nonelderly Adults in the United States From 2011 to 2017	16
Cardiologist Evaluation of Patients With Type 2 Myocardial Infarction	16
Severe Maternal Morbidity and Long-Term Risk of Cardiovascular Hospitalization	16
Text Message Medication Adherence Reminders Automated and Delivered at Scale Across Two Institutions: Testing the Nudge System: Pilot Study	16
2022 Interim Guidance to Health Care Providers for Basic and Advanced Cardiac Life Support in Adults, Children, and Neonates With Suspected or Confirmed COVID-19: From the Emergency Cardiovascular Car	16

Integrated Care in Atrial Fibrillation	15
Trends in Arterial Access Site Selection and Bleeding Outcomes Following Coronary Procedures, 2011–2018	15
Cardiovascular Disease Risk–Based Statin Utilization and Associated Outcomes in a Primary Prevention Cohort: Insights From a Large Health Care Network	15
Cost-Effectiveness of Empagliflozin in Patients With Heart Failure and Preserved Ejection Fraction	15
Show Me the Money	15
Association of Race and Ethnicity and Anticoagulation in Patients With Atrial Fibrillation Dually Enrolled in Veterans Health Administration and Medicare: Effects of Medicare Part D on Prescribing Dis	14
Practical Application of Patient-Reported Health Status Measures for Transcatheter Valve Therapies	14
Improving Cardiovascular Drug and Device Development and Evidence Through Patient-Centered Research and Clinical Trials	14
Trends in Consumer Wearable Devices With Cardiac Sensors in a Primary Care Cohort	14
Survival After In-Hospital Cardiac Arrest in Critically Ill Patients	14
Mendelian Randomization in Cardiovascular Research	14
Cardiovascular Disease Events and Mortality After Myocardial Infarction Among Black and White Adults	14
Conflicting Perspectives on the Value of Neprilysin Inhibition in Heart Failure Revealed During Development of a Decision Aid Focusing on Patient Costs for Sacubitril/Valsartan	14
Hybrid Training in Acute Cardiovascular Care	13
Economic Evaluation of Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure With Reduced Ejection Fraction	13
National Trends of Sex Disparity in the American College of Cardiology/American Heart Association Guideline Writing Committee Authors Over 15 Years	13
Sources of Hospital Variation in Postacute Care Spending After Cardiac Surgery	13
Cardiac Rehabilitation and the COVID-19 Pandemic: Persistent Declines in Cardiac Rehabilitation Participation and Access Among US Medicare Beneficiaries	13
Patient Perspectives on the Completion and Use of Patient-Reported Outcome Surveys in Routine Clinical Care for Heart Failure	13
2022 ACC/AHA Key Data Elements and Definitions for Chest Pain and Acute Myocardial Infarction: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Dat	13
Individual Psychosocial Resilience, Neighborhood Context, and Cardiovascular Health in Black Adults	13
Palliative Care Across the Life Span for Children With Heart Disease: A Scientific Statement From the American Heart Association	13
Toward Dynamic Risk Prediction of Outcomes After Coronary Artery Bypass Graft: Improving Risk Prediction With Intraoperative Events Using Gradient Boosting	13
Socioeconomic Status and Outcomes in Heart Failure With Reduced Ejection Fraction From Asia	13
Association of Medicaid Expansion With Rates of Utilization of Cardiovascular Therapies Among Medicaid Beneficiaries Between 2011 and 2018	13
Lipid Testing, Lipid-Modifying Therapy, and PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibitor Eligibility in 27 979 Patients With Incident Acute Coronary Syndrome	12
2020 Update to the 2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter: A Report of the American College of Cardiology/American Heart Associati	12
Cause of Death Among Patients With Peripheral Artery Disease	12
Relationship Between Social Determinants of Health and Antihypertensive Medication Adherence in a Medicaid Cohort	12
Estimation of the Absolute Risk of Cardiovascular Disease and Other Events: Issues With the Use of Multiple Fine-Gray Subdistribution Hazard Models	12
Benefits and Harms of Hypertension and High-Normal Labels: A Randomized Experiment	11
Longer-Term Results of a Universal Electronic Consultation Program at the Cardiology Department of a Galician Healthcare Area	11
Long-Term Prognosis of Patients With Coexisting Obesity and Malnutrition After Acute Myocardial Infarction: A Cohort Study	11
Anticoagulation Treatment and Outcomes of Venous Thromboembolism by Weight and Body Mass Index: Insights From the Veterans Health Administration	11
Reclassification, Thromboembolic, and Major Bleeding Outcomes Using Different Estimates of Renal Function in Anticoagulated Patients With Atrial Fibrillation: Insights From the PREFER-in-AF and PREFER	11
In-Hospital Cardiac Arrest Survival in the United States During and After the Initial Novel Coronavirus Disease 2019 Pandemic Surge	11
Indications for Left Atrial Appendage Occlusion in the United States and Associated In-Hospital Outcomes: Results From the NCDR LAAO Registry	11
Trends of Coronary Artery Bypass Grafting Performance in a Cohort of Hospitals in China Between 2013 and 2018	11
Strategies to Reduce Low-Value Cardiovascular Care: A Scientific Statement From the American Heart Association	11
Associations of Medicaid Expansion With Access to Care, Severity, and Outcomes for Acute Ischemic Stroke	11
Provider Care Team Segregation and Operative Mortality Following Coronary Artery Bypass Grafting	11
Effectiveness of Stroke Early Supported Discharge	11
Comparative Effectiveness of Dual Antiplatelet Therapy With Aspirin and Clopidogrel Versus Aspirin Monotherapy in Mild-to-Moderate Acute Ischemic Stroke According to the Risk of Recurrent Stroke	11
Validity of International Classification of Diseases (ICD)-10 Diagnosis Codes for Identification of Acute Heart Failure Hospitalization and Heart Failure with Reduced Versus Preserved Ejection Fractio	11
Association Between Early Trauma and Ideal Cardiovascular Health Among Black Americans	11
Association Between Industry Marketing Payments and Prescriptions for PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibitors in the United States	10
Exposure to Neighborhood-Level Racial Residential Segregation in Young Adulthood to Midlife and Incident Subclinical Atherosclerosis in Black Adults: The Coronary Artery Risk Development in Young Adul	10
Joint Modeling of Longitudinal Markers and Time-to-Event Outcomes: An Application and Tutorial in Patients After Surgical Repair of Transposition of the Great Arteries	10
Monotherapy Anticoagulation to Expedite Home Treatment of Patients Diagnosed With Venous Thromboembolism in the Emergency Department: A Pragmatic Effectiveness Trial	10
Risk Stratification of Patients Undergoing Percutaneous Repair of Mitral and Tricuspid Valves Using a Multidimensional Geriatric Assessment	10
Prior Authorization, Copayments, and Utilization of Sacubitril/Valsartan in Medicare and Commercial Plans in Patients With Heart Failure With Reduced Ejection Fraction	10
Best Practices for Education and Training of Resuscitation Teams for In-Hospital Cardiac Arrest	10
Long-Term Effect of Weight Regain Following Behavioral Weight Management Programs on Cardiometabolic Disease Incidence and Risk: Systematic Review and Meta-Analysis	9
Trajectories of Pain After Cardiac Surgery: Implications for Measurement, Reporting, and Individualized Treatment	9
Screening for Intracranial Aneurysms in Coarctation of the Aorta	9
Validation of Cardiovascular End Points Ascertainment Leveraging Multisource Electronic Health Records Harmonized Into a Common Data Model in the ADAPTABLE Randomized Clinical Trial	9
Hospital and Operator Variation in Cardiac Rehabilitation Referral and Participation After Percutaneous Coronary Intervention: Insights From Blue Cross Blue Shield of Michigan Cardiovascular Consortiu	9
Social Determinants of Adherence to COVID-19 Risk Mitigation Measures Among Adults With Cardiovascular Disease	9
Neighborhoods and Cardiovascular Health: A Scientific Statement From the American Heart Association	9
Comparative Methodological Assessment of the Randomized GLOBAL LEADERS Trial Using Total Ischemic and Bleeding Events	9
Reimagining Evidence Generation for Heart Failure and the Role of Integrated Health Care Systems	9
Perioperative Considerations for Pediatric Patients With Congenital Heart Disease Presenting for Noncardiac Procedures: A Scientific Statement From the American Heart Association	9
Target: Stroke Was Associated With Faster Intravenous Thrombolysis and Improved One-Year Outcomes for Acute Ischemic Stroke in Medicare Beneficiaries	9
Potential Impact of the 2019 ACC/AHA Guidelines on the Primary Prevention of Cardiovascular Disease Recommendations on the Inappropriate Routine Use of Aspirin and Aspirin Use Without a Recommended In	9
Comparison of Investigator-Reported and Clinical Event Committee–Adjudicated Outcome Events in GLASSY	9
Contributions of Structural Racism to the Food Environment: A Photovoice Study of Black Residents With Hypertension in Baltimore, MD	9
Changes in Home Blood Pressure Monitored Among Elderly Patients With Hypertension During the COVID-19 Outbreak: A Longitudinal Study in China Leveraging a Smartphone-Based Application	9
Efforts to Improve Survival Outcomes of Out-of-Hospital Cardiac Arrest in China: BASIC-OHCA	8
Rationale and Design of the SAFE-PAD Study	8
Practice Patterns and Outcomes Associated With Anticoagulation Use Following Sepsis Hospitalizations With New-Onset Atrial Fibrillation	8
The New Adult Heart Allocation Policy	8
Use of Artificial Intelligence Tools Across Different Clinical Settings	8
Lipid-Lowering Therapy Use and Intensification Among United States Veterans Following Myocardial Infarction or Coronary Revascularization Between 2015 and 2019	8
Generalizability of DAPA-CKD to the United States	8
Ten Steps Toward Improving In-Hospital Cardiac Arrest Quality of Care and Outcomes	8
Examination of Sexual Identity Differences in the Prevalence of Hypertension and Antihypertensive Medication Use Among US Adults: Findings From the Behavioral Risk Factor Surveillance System	8
The Cardiovascular Quality Improvement and Care Innovation Consortium	7
Early Increased Physical Activity, Cardiac Rehabilitation, and Survival After Implantable Cardioverter-Defibrillator Implantation	7
Association of State Medicaid Expansion Status With Hypertensive Disorders of Pregnancy in a Singleton First Live Birth	7
Gaps in Guideline-Based Lipid-Lowering Therapy for Secondary Prevention in the United States: A Retrospective Cohort Study of 322 153 Patients	7

Reflections on the Values of Community-Based Participatory Research in Supporting Mobile Health Technology Use	7
Increasing Uptake of Depression Screening and Treatment Guidelines in Cardiac Patients: A Behavioral and Implementation Science Approach to Developing a Theory-Informed, Multilevel Implementation Stra	7
Progression of Preclinical Heart Failure: A Description of Stage A and B Heart Failure in a Community Population	7
Coronary Artery Bypass Surgery in Patients With COVID-19	7
Relation of Household Income to Access and Adherence to Combination Sacubitril/Valsartan in Heart Failure: A Retrospective Analysis of Commercially Insured Patients	7
Personalized, Electronic Health Record–Integrated Decision Aid for Stroke Prevention in Atrial Fibrillation: A Small Cluster Randomized Trial and Qualitative Analysis of Efficacy and Acceptability	7
Frontiers of Upstream Stroke Prevention and Reduced Stroke Inequity Through Predicting, Preventing, and Managing Hypertension and Atrial Fibrillation	7
Interim Guidance for Emergency Medical Services Management of Out-of-Hospital Cardiac Arrest During the COVID-19 Pandemic	7
Cardiovascular Risk Assessment Using Artificial Intelligence-Enabled Event Adjudication and Hematologic Predictors	7
Can Pay-for Performance Incentive Levels be Determined Using a Cost-Effectiveness Framework?	7
Competitive Sports, the Coronavirus Disease 2019 Pandemic, and Big Ten Athletics	7
Quantifying Blood Pressure Visit-to-Visit Variability in the Real-World Setting: A Retrospective Cohort Study	7
Variation in Cardiac Rehabilitation Participation During Aortic Valve Replacement Episodes of Care	7
Examining Neighborhood Socioeconomic Status as a Mediator of Racial/Ethnic Disparities in Hypertension Control Across Two San Francisco Health Systems	7
Implementation of a Machine-Learning Algorithm in the Electronic Health Record for Targeted Screening for Familial Hypercholesterolemia: A Quality Improvement Study	7
Systemizing the Evaluation of Acute Heart Failure in the Emergency Department	7
Leveraging Remote Physiologic Monitoring in the COVID-19 Pandemic to Improve Care After Cardiovascular Hospitalizations	6
American Heart Association Precision Medicine Platform Addresses Challenges in Data Sharing	6
Establishing Thresholds for Minimal Clinically Important Differences for the Peripheral Artery Disease Questionnaire	6
Addressing Gaps in Racial/Ethnic Representation in Familial Hypercholesterolemia Registries	6
Accuracy of Cardiovascular Trial Outcome Ascertainment and Treatment Effect Estimates from Routine Health Data: A Systematic Review and Meta-Analysis	6
Cardiometabolic Risk Factor Control During Times of Crises and Beyond	6
Early Stage and Established Hypertension in Sub-Saharan Africa: Results From Population Health Surveys in 17 Countries, 2010–2017	6
Cost Effectiveness of Interhospital Transfer for Mechanical Thrombectomy of Acute Large Vessel Occlusion Stroke	6
Statin Prescribing Patterns During In-Person and Telemedicine Visits Before and During the COVID-19 Pandemic	6
Improving Outcome Predictions for Patients Receiving Mechanical Circulatory Support by Optimizing Imputation of Missing Values	6
Global Cardio Oncology Registry (G-COR): Registry Design, Primary Objectives, and Future Perspectives of a Multicenter Global Initiative	6
Comparison of 0/3-Hour Rapid Rule-Out Strategies Using High-Sensitivity Cardiac Troponin I in a US Emergency Department	6
Trends of Concomitant Diabetes and Peripheral Artery Disease and Lower Extremity Amputation in US Medicare Patients, 2007 to 2019	6
Financial Toxicity With Cardiovascular Disease Management	6
Rates and Predictors of Patient Underreporting of Hospitalizations During Follow-Up After Acute Myocardial Infarction	6
Social Determinants of Cardiovascular Health in an Era of Rising Social Disadvantage	6
Incidence of Timely Outpatient Follow-Up Care After Emergency Department Encounters for Acute Heart Failure	6
Sociodemographic Disparities in Outpatient Cardiology Telemedicine During the COVID-19 Pandemic	6
One-Year Outcomes and Factors Associated With Mortality Following Acute Myocardial Infarction in Northern Tanzania	6
Integrating Community Health Workers into Community-Based Primary Care Practice Settings to Improve Blood Pressure Control Among South Asian Immigrants in New York City: Results from a Randomized Cont	6
Association of Cardiac Care Regionalization With Access, Treatment, and Mortality Among Patients With ST-Segment Elevation Myocardial Infarction	6
Contemporary Rates of Hospitalization for Heart Failure in Young and Middle-Aged Adults in a Diverse US State	6
Estimating Long-Term Health Utility Scores and Expenditures for Cardiovascular Disease From the Medical Expenditure Panel Survey	6
Recommendations and Associated Levels of Evidence for Statin Use in Primary Prevention of Cardiovascular Disease: A Comparison at Population Level of the American Heart Association/American College of	6
Safer Stroke-Dx Instrument: Identifying Stroke Misdiagnosis in the Emergency Department	6
Impact of Medicare’s Bundled Payments Initiative on Patient Selection, Payments, and Outcomes for Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting	6
Response by Chan to Letter Regarding Article, “In-Hospital Cardiac Arrest Survival in the United States During and After the Initial Novel Coronavirus Disease 2019 Pandemic Surge”	5
Traditional Chinese Medicine in Treating Hypertension	5
Kidney Function and Potassium Monitoring After Initiation of Renin-Angiotensin-Aldosterone System Blockade Therapy and Outcomes in 2 North American Populations	5
Determinants of Value in Coronary Artery Bypass Grafting	5
Influence of Hospital Characteristics on Hospital Transfer Destinations for Patients With Stroke	5
Changes in Emergency Department Arrival Times for Acute Myocardial Infarction During the COVID-19 Pandemic Suggest Delays in Care Seeking	5
Early Termination of Acute Stroke Randomized Controlled Trials Published Between 2013 and 2020: A Systematic Review	5
Comparative Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin Among Adults With Cancer and Atrial Fibrillation	5
Development and Piloting of a Community-Partnered Heart Failure Training Course for Home Health Care Workers	5
Patients With Acute Coronary Syndromes Admitted to Contemporary Cardiac Intensive Care Units: Insights From the CCCTN Registry	5
Does Dog Ownership Really Prolong Survival?	5
Long-Term Bleeding Risk Prediction with Dual Antiplatelet Therapy After Acute Coronary Syndromes Treated Without Revascularization	5
Echocardiographic and Electrocardiographic Abnormalities Among Elderly Adults With Cardiovascular Disease in Rural South Africa	5
Catheterization Laboratory Activation Time in Patients Transferred With ST-Segment–Elevation Myocardial Infarction: Insights From the Mission: Lifeline STEMI Accelerator-2 Project	5
Cardiovascular- and Bleeding-Related Hospitalization Rates With Edoxaban Versus Warfarin in Patients With Atrial Fibrillation Based on Results of the ENGAGE AF–TIMI 48 Trial	5
Patient Preferences for Pharmaceutical and Device-Based Treatments for Uncontrolled Hypertension: Discrete Choice Experiment	5
Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin II Receptor Blockers	5
Association of Clinical Setting With Sociodemographics and Outcomes Following Endovascular Femoropopliteal Artery Revascularization in the United States	5
Improvement in Kansas City Cardiomyopathy Questionnaire Scores After a Self-Care Intervention in Patients With Acute Heart Failure Discharged From the Emergency Department	5
Optimal Methods for Reducing Proxy-Introduced Bias on Patient-Reported Outcome Measurements for Group-Level Analyses	5
Guideline-Directed Medical Therapy Attainment and Outcomes in Dialysis-Requiring Versus Nondialysis Chronic Kidney Disease in the ISCHEMIA-CKD Trial	5
Evidence-Based Policy Making for Public Health Interventions in Cardiovascular Diseases: Formally Assessing the Feasibility of Clinical Trials	5
Electronic Health Record Integration of Predictive Analytics to Select High-Risk Stable Patients With Non–ST-Segment–Elevation Myocardial Infarction for Intensive Care Unit Admission	5
Evidence-Based Process Performance Measures and Clinical Outcomes in Patients With Incident Heart Failure With Reduced Ejection Fraction: A Danish Nationwide Cohort Study	5
Inflection Point	5
Innovative Managed Care May Be Related to Improved Prognosis for Acute Myocardial Infarction Survivors	5
Long-Term Outcomes for Out-of-Hospital Cardiac Arrest in Elderly Patients: An Analysis of Cardiac Arrest Registry to Enhance Survival Data Linked to Medicare Files	5
Validation of the International Classification of Diseases, Tenth Revision Code for the National Institutes of Health Stroke Scale Score	5
Artificial Intelligence–Enabled Model for Early Detection of Left Ventricular Hypertrophy and Mortality Prediction in Young to Middle-Aged Adults	5
Status of Maternal Cardiovascular Health in American Indian and Alaska Native Individuals: A Scientific Statement From the American Heart Association	5
Why Is Intravascular Ultrasound Guidance Underutilized in Percutaneous Coronary Intervention?: It Is Not “All About the Benjamins”	5
2022 AHA/ACC Key Data Elements and Definitions for Cardiovascular and Noncardiovascular Complications of COVID-19: A Report of the American College of Cardiology/American Heart Association Task Force	5
Understanding Baseline Physical Activity in Cardiac Rehabilitation Enrollees Using Mobile Health Technologies	5
Approval, Evidence, and “Off-Label” Device Utilization: The Patent Foramen Ovale Closure Story	5
Association Between Electrocardiographic Age and Cardiovascular Events in Community Settings: The Framingham Heart Study	5
The Accreditation Council for Graduate Medical Education Mandates That You Attempt to Enhance Diversity in Your Cardiology Program	5
Urban Spatial Accessibility of Primary Care and Hypertension Control and Awareness on Chicago’s South Side: A Study From the COMPASS Cohort	5
Thirty-Day and 90-Day Episode of Care Spending Following Heart Failure Hospitalization Among Medicare Beneficiaries	4
Identifying and Addressing Gaps in the Care of Patients With Severe Valve Disease	4
Cost-Effectiveness of Intravascular Imaging-Guided Complex PCI: Prespecified Analysis of RENOVATE-COMPLEX-PCI Trial	4
Development of the Elective Outpatient Percutaneous Coronary Intervention Episode–Based Cost Measure	4
Maintaining a National Acute Kidney Injury Risk Prediction Model to Support Local Quality Benchmarking	4
Spouse’s Cardiovascular Disease As a Risk Factor for Cardiovascular Disease in Middle-Aged Adults: A Matched-Pair Cohort Study	4
Nationwide Implementation of a Population Management Dashboard for Monitoring Direct Oral Anticoagulants: Insights From the Veterans Affairs Health System	4
Relationship Between Social Vulnerability Indicators and Trial Participant Attrition: Findings From the HYVALUE Trial	4
Machine Learning in Clinical Journals	4
Unblinded and Blinded N-of-1 Trials Versus Usual Care: A Randomized Controlled Trial to Increase Statin Uptake in Primary Care	4
Reach Out Emergency Department: A Randomized Factorial Trial to Determine the Optimal Mobile Health Components to Reduce Blood Pressure	4
Burning in “Other Suns”: The Effects of Residential Segregation on Cardiovascular Health	4
Comparative Effectiveness Research and Cardiovascular Device Registries: Aligning Policy and Methods	4
Adherence to Pediatric Universal Cholesterol Testing Guidelines Across Body Mass Index Categories: A CER 2 Cohort Study	4
Association Between Increased Hospital Reimbursement for Cardiac Rehabilitation and Utilization of Cardiac Rehabilitation by Medicare Beneficiaries	4
True Negatives	4